GlobeImmune, Inc. (GBIM)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Feb 12, 2026

GlobeImmune Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2015FY 2014FY 2013FY 2012FY 2011
Period Ending
Feb '26 Dec '15 Dec '14 Dec '13 Dec '12 Dec '11
02244---
Market Cap Growth
-99.97%-48.99%----
Enterprise Value
-1125---
Last Close Price
0.003.877.59---
PS Ratio
0.003.457.31---
PB Ratio
0.007.457.79---
P/TBV Ratio
0.007.457.79---
EV/Sales Ratio
-1.704.15---
Debt / Equity Ratio
----0.02--
Debt / EBITDA Ratio
---0.02--
Debt / FCF Ratio
---0.05--
Asset Turnover
0.490.430.463.861.330.25
Quick Ratio
2.102.343.250.920.241.13
Current Ratio
2.282.633.441.060.351.16
Return on Equity (ROE)
-66.24%-64.41%----
Return on Assets (ROA)
-10.26%-11.58%-28.21%82.42%-22.55%-38.01%
Return on Capital Employed (ROCE)
-36.80%-38.00%-44.10%766.10%96.50%-292.70%
Earnings Yield
-359753.91%-12.43%-37.27%---
FCF Yield
-1028991.13%-32.19%-23.71%---
Buyback Yield / Dilution
-32.85%-97.33%-3050.27%-3.52%-1.74%-2.52%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.